Clinical Trial

Endocalyx in Treatment Resistent Hypertension

Name: Endocalyx in Treatment Resistent Hypertension — clinical trial record (NCT06940011)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GLYCO-TRH

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this randomized, double-blind, placebo-controlled study is to assess whether the food supplement Endocalyx lowers blood pressure in patients with treatment resistant hypertension.

Trial Details

NCT Number	NCT06940011
Lead Sponsor	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Collaborators: Dutch Heart Foundation, Dutch Kidney Foundation, Microvascular Health Solutions LLC
Conditions	Treatment Resistant Hypertension
Enrollment	64 participants
Start Date	2025-01-21
Primary Completion	2027-12-01 (estimated)
Study Completion	2028-01-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-23